Related Experiment Video

Updated: Oct 4, 2025

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

9.2K

CX-5461 is a potent immunosuppressant which inhibits T cell-mediated alloimmunity via p53-DUSP5

Guopin Pan1, Jing Zhang2, Yu Han2

  • 1Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China; Shandong Key Laboratory of Cardiovascular Proteomics and Department of Geriatric Medicine, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong Province, China; Henan International Joint Laboratory of Cardiovascular Remodeling and Drug Intervention, Xinxiang Medical University, Xinxiang, Henan Province, China.

Pharmacological Research
|February 8, 2022
PubMed

Insights

CX-5461, a novel RNA polymerase I inhibitor, demonstrates potent immunosuppressive effects by preventing organ transplant rejection. It expands regulatory T cells and inhibits key immune mediators, offering a promising alternative to current anti-rejection therapies.

Area of Science:

  • Immunology
  • Pharmacology
  • Transplantation Biology

Background:

  • CX-5461 is a first-in-class selective RNA polymerase I inhibitor with previously identified anti-inflammatory activities.
  • This study investigates the potential immunosuppressive effects of CX-5461 and elucidates its underlying mechanisms.

Purpose of the Study:

  • To characterize the immunosuppressive properties of CX-5461.
  • To explore the molecular mechanisms responsible for CX-5461-mediated immunosuppression.
  • To evaluate CX-5461's efficacy in preventing allograft rejection.

Main Methods:

  • Utilized allogeneic skin and heterotopic heart transplantation models in mice and rats, respectively.
  • Assessed T cell activation and proliferation in vitro.
  • Analyzed the expression of key immune mediators like interferon-gamma and interleukin-2.
  • Investigated the role of the p53-DUSP5-Erk1/2 pathway in CX-5461's mechanism of action.

Main Results:

  • CX-5461 effectively prevented acute allograft rejection in both transplantation models.
  • Treatment with CX-5461 led to a consistent expansion of the regulatory T cell population.
  • CX-5461 inhibited agonist-induced T cell activation and suppressed the expression of interferon-gamma and interleukin-2.
  • The immunosuppressive effects were partly mediated by the p53-DUSP5 axis, antagonizing the Erk1/2 pathway.

Conclusions:

  • CX-5461 exhibits potent immunosuppressive activity, preventing acute allograft rejection.
  • The drug promotes regulatory T cell expansion and inhibits key T cell-mediated immune responses.
  • CX-5461 represents a promising candidate for a novel class of immunosuppressants, potentially serving as an alternative to existing anti-rejection therapies.
Keywords:
Acute rejectionAlloimmunityCX-5461DUSP5P53T cell receptor signaling

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

9.1K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.5K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
74.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
7.5K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.5K